Purchases and Sales Made in Q2 2022 in Aurinia Pharmaceuticals Inc. (AUPH)
This table provides information about the institutional ownership of Aurinia Pharmaceuticals Inc. (AUPH) during Q2 2022. The information is specifically focused on institutions that hold shares of Aurinia Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-87.1KClosed |
$779K - $1.11M
|
0
$0
|
|
|
Jul 28, 2022
Q2 2022
|
Oak Ridge Investments LLC
|
SELL
|
- |
-101KClosed |
$905K - $1.29M
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-102K- 21.21% |
$913K - $1.31M
|
379K
$3.03M
|
|
|
Aug 15, 2022
Q2 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-107KClosed |
$960K - $1.37M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-112KClosed |
$1M - $1.43M
|
0
$0
|
|
|
Aug 03, 2022
Q2 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-119K- 65.68% |
$1.07M - $1.53M
|
62.4K
$500K
|
|
|
Aug 15, 2022
Q2 2022
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-144K- 79.67% |
$1.28M - $1.84M
|
36.6K
$293K
|
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-152K- 4.99% |
$1.36M - $1.94M
|
2.89M
$23.2M
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-152K- 4.99% |
$1.36M - $1.94M
|
2.89M
$23.2M
|
|
|
Aug 04, 2022
Q2 2022
|
State Of New Jersey Common Pension Fund D
|
SELL
|
- |
-160KClosed |
$1.43M - $2.05M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Antara Capital LP
New York, NY |
SELL
|
- |
-189KClosed |
$1.69M - $2.41M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-206K- 10.71% |
$1.84M - $2.64M
|
1.72M
$13.8M
|
|
|
Aug 15, 2022
Q2 2022
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-227KClosed |
$2.03M - $2.91M
|
0
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-250K- 51.74% |
$2.24M - $3.2M
|
233K
$1.87M
|
|
|
Aug 15, 2022
Q2 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-274KClosed |
$2.46M - $3.51M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-280K- 24.36% |
$2.51M - $3.58M
|
869K
$6.96M
|
|
|
Aug 15, 2022
Q2 2022
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-345KClosed |
$3.09M - $4.41M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Stifel Financial Corp
St. Louis, MO |
SELL
|
- |
-375K- 26.49% |
$3.36M - $4.81M
|
1.04M
$8.34M
|
|
|
Aug 16, 2022
Q2 2022
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-429K- 98.68% |
$3.84M - $5.49M
|
5.76K
$46.1K
|
|
|
Jul 29, 2022
Q2 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-779K- 97.24% |
$6.97M - $9.97M
|
22.1K
$177K
|
|
|
Aug 12, 2022
Q2 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-1.1M- 64.67% |
$9.81M - $14M
|
599K
$4.79M
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.33M- 64.83% |
$11.9M - $17M
|
720K
$5.77M
|